Abstract
The appropriate age at which to perform endometrial biopsy for abnormal uterine bleeding
(AUB) is controversial. This study aimed to determine the prevalence of malignant
and premalignant pathologies in women aged 41–49 years with AUB and without risk factors
for endometrial cancer. Records of women who had undergone a biopsy at the gynaecology
clinic of the Centre hospitalier de l'Université de Montréal between 2014 and 2018
were reviewed. Of the 209 women included in the study, 2 had atypical hyperplasia,
which resolved without treatment, and 3 had hyperplasia without atypia. The remaining
women had benign results, showing that the prevalence of malignant and premalignant
endometrial pathologies is low in this subgroup of patients.
Résumé
L’âge auquel il convient de réaliser une biopsie de l’endomètre en raison de saignements
utérins anormaux (SUA) est controversé. Cette étude visait à déterminer la prévalence
des pathologies malignes et prémalignes chez les femmes de 41 à 49 ans atteintes de
SUA n’ayant aucun facteur de risque pour le cancer de l’endomètre. Les dossiers des
femmes ayant subi une biopsie entre 2014 et 2018 à la clinique de gynécologie du Centre
hospitalier de l’Université de Montréal ont été examinés. Des 209 femmes incluses
dans l’étude, 2 avaient une hyperplasie atypique, qui s’est résorbée sans traitement,
et 3 présentaient une hyperplasie sans atypie. Chez les autres femmes, les résultats
se sont révélés bénins, ce qui montre que la prévalence des pathologies endométriales
malignes et prémalignes est faible dans ce sous-groupe de patientes.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Obstetrics and Gynaecology CanadaAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
Committee CCSA. Canadian cancer statistics 2021. Available at: cancer.ca/Canadian-Cancer-Statistics-2021-EN. Accessed January 10, 2022.
- Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a gynecologic oncology group study.Cancer. 2006; 106: 812-819
- No. 292-abnormal uterine bleeding in pre-menopausal women.J Obstet Gynaecol Can. 2018; 40: e391-e415
- Premenopausal abnormal uterine bleeding and risk of endometrial cancer.BJOG. 2017; 124: 404-411
- No. 291-epidemiology and investigations for suspected endometrial cancer.J Obstet Gynaecol Can. 2018; 40: e703-e711
- Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women.Obstet Gynecol. 2012; 120: 197-206
menstrual bleeding. Heavy menstrual bleeding- a: evidence reviews for diagnostic test accuracy in investigation for women presenting with heavy menstrual bleeding. Available at: https://www.nice.org.uk/guidance/ng88/evidence/evidence-review-a-diagnostic-test-accuracy-in-investigation-for-women-presenting-with-heavy-menstrual-bleeding-pdf-4782293101. Accessed September 15, 2019.
- Female genital tumours.International Agency for Research on Cancer, France2020: 250
- An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding.Am J Obstet Gynecol. 1999; 181: 525-529
- Endometrial biopsy.Am Fam Physician. 2001; 63 (7-41. Available at): 1131-1135
Article info
Publication history
Published online: June 23, 2022
Accepted:
May 30,
2022
Received:
February 12,
2022
Footnotes
Disclosures: The authors declare they have nothing to disclose.
All authors have indicated they meet the journal’s requirements for authorship.
Identification
Copyright
© 2022 The Society of Obstetricians and Gynaecologists of Canada/La Société des obstétriciens et gynécologues du Canada. Published by Elsevier Inc. All rights reserved.
